Cargando…

Population Analysis of Pharmacogenetic Polymorphisms Related to Acute Lymphoblastic Leukemia Drug Treatment

This study aimed to evaluate in the Brazilian population, the genotypes and population frequencies of pharmacogenetic polymorphisms involved in the response to drugs used in treatment of acute lymphoblastic leukemia (ALL), and to compare the data with data from the HapMap populations. There was sign...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiabai, Marcela A., Lins, Tulio C. L., Pogue, Robert, Pereira, Rinaldo W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2012
Materias:	Other
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826589/ https://www.ncbi.nlm.nih.gov/pubmed/22430191 http://dx.doi.org/10.3233/DMA-2011-0884

Ejemplares similares

Pharmacogenetic testing for thiopurine drugs in Brazilian acute lymphoblastic leukemia patients
por: Suarez-Kurtz, Guilherme, et al.
Publicado: (2023)

Pharmacogenetics of asparaginase in acute lymphoblastic leukemia
por: Abaji, Rachid, et al.
Publicado: (2019)

Characterization of pharmacogenetic markers related to Acute Lymphoblastic Leukemia toxicity in Amazonian native Americans population
por: de Carvalho, Darlen Cardoso, et al.
Publicado: (2020)

Pharmacogenetics of pediatric acute lymphoblastic leukemia in Uruguay: adverse events related to induction phase drugs
por: Burgueño-Rodríguez, Gabriela, et al.
Publicado: (2023)

Implementation of Pharmacogenetics to Individualize Treatment Regimens for Children with Acute Lymphoblastic Leukemia
por: Maamari, Dimitri, et al.
Publicado: (2020)

Pharmacogenetic Analysis of Pediatric Patients with Acute Lymphoblastic Leukemia: A Possible Association between Survival Rate and ITPA Polymorphism
por: Kim, Hyery, et al.
Publicado: (2012)

The Fractal Dimension of Nuclear Chromatin as a Prognostic Factor in Acute Precursor B Lymphoblastic Leukemia
por: Adam, Randall L., et al.
Publicado: (2006)

Population analysis of vitamin D receptor polymorphisms and the role of genetic ancestry in an admixed population
por: Lins, Tulio C., et al.
Publicado: (2011)

Pharmacogenetics of MicroRNAs and MicroRNAs Biogenesis Machinery in Pediatric Acute Lymphoblastic Leukemia
por: López-López, Elixabet, et al.
Publicado: (2014)

Screening of Novel Pharmacogenetic Candidates for Mercaptopurine-Induced Toxicity in Patients With Acute Lymphoblastic Leukemia
por: Cao, Minyuan, et al.
Publicado: (2020)

Pharmacogenetics of induction therapy-related toxicities in childhood acute lymphoblastic leukemia patients treated with UKALL 2003 protocol
por: Aslam, Sara, et al.
Publicado: (2021)

Pharmacogenetics of the Central Nervous System—Toxicity and Relapse Affecting the CNS in Pediatric Acute Lymphoblastic Leukemia
por: Sági, Judit C., et al.
Publicado: (2021)

A Pharmacogenetic Study of VDR fok1 and TYMS Polymorphisms and Their Association With Glucocorticoid-Induced Osteonecrosis in Egyptian Children With Acute Lymphoblastic Leukemia
por: ElHarouni, Dina, et al.
Publicado: (2018)

TagSNP transferability and relative loss of variability prediction from HapMap to an admixed population
por: Lins, Tulio C, et al.
Publicado: (2009)

Elevated Asymmetric Dimethylarginine in Young Adult Survivors of Childhood Acute Lymphoblastic Leukemia: A Preliminary Report
por: Sulicka, Joanna, et al.
Publicado: (2012)

Flow Cytometric DNA Index and Karyotype in Childhood Lymphoblastic Leukemia
por: Forestier, Erik, et al.
Publicado: (1998)

Thiopurine methyltransferase polymorphisms in children with acute lymphoblastic leukemia
por: Linga, Vijay Gandhi, et al.
Publicado: (2014)

Pharmacogenetics: polymorphism and genotype-phenotype correlation of drug response in indian population
por: Padh, Harish
Publicado: (2014)

The Role of Interleukin-15 Polymorphisms in Adult Acute Lymphoblastic Leukemia
por: Lin, Dandan, et al.
Publicado: (2010)

ITPA Polymorphisms and the Incidence of Toxicities in Children with Acute Lymphoblastic Leukemia
por: Svasdisant, Patpetra, et al.
Publicado: (2023)

Association of TLX1 gene polymorphisms with the risk of acute lymphoblastic leukemia and B lineage acute lymphoblastic leukemia in Han Chinese children
por: Mei, Endian, et al.
Publicado: (2020)

Use of Pharmacogenetic Drugs by the Dutch Population
por: Alshabeeb, Mohammad A., et al.
Publicado: (2019)

Acute lymphoblastic leukemia
por: Schrappe, Martin
Publicado: (2018)

APEX1 Polymorphism and Mercaptopurine-Related Early Onset Neutropenia in Pediatric Acute Lymphoblastic Leukemia
por: Kim, Hyery, et al.
Publicado: (2018)

Impact of genetic polymorphisms on chemotherapy toxicity in childhood acute lymphoblastic leukemia
por: Gervasini, Guillermo, et al.
Publicado: (2012)

Genetic Polymorphism of Thiopurine S-methyltransferase in Children with Acute Lymphoblastic Leukemia in Jordan
por: Alsous, Mervat, et al.
Publicado: (2018)

MTHFR polymorphisms in childhood acute lymphoblastic leukemia: influence on methotrexate therapy
por: Umerez, Maitane, et al.
Publicado: (2017)

Association of MTHFR Polymorphisms and Chromosomal Abnormalities in Leukemia
por: Sinthuwiwat, Thivaratana, et al.
Publicado: (2012)

Polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and susceptibility to pediatric acute lymphoblastic leukemia in a German study population
por: Schnakenberg, Eckart, et al.
Publicado: (2005)

Association of Toll-like receptors polymorphisms with the risk of acute lymphoblastic leukemia in the Brazilian Amazon
por: Xabregas, Lilyane Amorim, et al.
Publicado: (2022)

Pre T-Cell Receptor Alpha (pTα) Expression Patterns and Functional Analysis in Human T-Cell Lymphoblastic Leukemia
por: Ivanyi, Philipp, et al.
Publicado: (2010)

Diabetes-Related Autoantibodies in Children With Acute Lymphoblastic Leukemia
por: Bizzarri, Carla, et al.
Publicado: (2012)

Call for Manuscript Submissions for a Thematic eJIFCC Issue on “Pharmacogenetics and Personalized Therapy”
por: van Schaik, Ron H. N., et al.
Publicado: (2022)

Polymorphisms of the thiopurine methyl transferase gene in healthy and acute lymphoblastic leukemia mestizos
por: Candelaria, Myrna, et al.
Publicado: (2007)

Association of the independent polymorphisms in CDKN2A with susceptibility of acute lymphoblastic leukemia
por: Zhou, Xueyan, et al.
Publicado: (2018)

MYBL2 Gene Polymorphism Is Associated With Acute Lymphoblastic Leukemia Susceptibility in Children
por: Guo, Haixia, et al.
Publicado: (2021)

The influence of MTHFR genetic polymorphisms on methotrexate therapy in pediatric acute lymphoblastic leukemia
por: Shen, Yaqing, et al.
Publicado: (2021)

Acute lymphoblastic leukemia in adults
por: Ribera, Josep-Maria
Publicado: (2011)

Pediatric acute lymphoblastic leukemia
por: Inaba, Hiroto, et al.
Publicado: (2020)

Association between Methylenetetrahydrofolate Reductase (MTHFR) Gene Polymorphisms and Susceptibility to Childhood Acute Lymphoblastic Leukemia in an Iranian Population
por: Bahari, Gholamreza, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2uak16pjhrc7sf4dlrhhg1li7l